Evidence map›Paper›PMID 24824755›Full record

ArticlePloS one2014

BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.

Niroop Kaza, Latika Kohli, Christopher D Graham, Barbara J Klocke, Steven L Carroll, Kevin A Roth

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Niroop KazaDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Latika KohliDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Christopher D GrahamDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Barbara J KlockeDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Steven L CarrollDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Kevin A RothDepartment of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
University of Alabama at Birmingham · US

Funding

ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
UAB Neuroscience Core CenterP30NS047466 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STANDAERT, DAVID G. · 2005 to 2019
$8.5M
Molecular Characterization of Neural Stem Cell ApoptosisR01NS041962 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROTH, KEVIN A · 2003 to 2012
$3.0M
Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath TumorsR01CA122804 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CARROLL, STEVEN L. · 2008 to 2012
$1.5M
Multi-Modal Lysosomotropic Death Therapy for Malignant Peripheral Nerve Sheath TuR01CA134773 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROTH, KEVIN A · 2009 to 2011
$722k
NCI NIH HHS CA122804NCI NIH HHS CA134773NCI NIH HHS R01 CA122804NCI NIH HHS R01 CA134773NIAMS NIH HHS P30 AR048311NINDS NIH HHS NS41962NINDS NIH HHS P30 NS047466NINDS NIH HHS R01 NS041962
6 · The paper itself

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive Schwann cell-derived sarcomas and are the leading cause of mortality in patients with neurofibromatosis type 1 (NF1). Current treatment modalities have been largely ineffective, resulting in a high rate of MPNST recurrence and poor five-year patient survival. This necessitates the exploration of alternative chemotherapeutic options for MPNST patients. This study sought to assess the cytotoxic effect of the BH3-mimetic AT101 [(-)-gossypol] on MPNST cells in vitro and to identify key regulators of AT101-induced MPNST cell death. We found that AT101 caused caspase-independent, non-apoptotic MPNST cell death, which was accompanied by autophagy and was mediated through HIF-1α induced expression of the atypical BH3-only protein BNIP3. These effects were mediated by intracellular iron chelation, a previously unreported mechanism of AT101 cytotoxicity.

Indexed as

Antineoplastic Agents, PhytogenicAutophagyCell DeathCell Line, TumorDose-Response Relationship, DrugGossypolHumansHypoxia-Inducible Factor 1, alpha SubunitIronMembrane ProteinsNeurilemmomaProto-Oncogene ProteinsSchwann CellsAntineoplastic Agents, PhytogenicBNIP3 protein, humanGossypolgossypol acetic acidHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitIronMembrane ProteinsProto-Oncogene Proteins

Identifiers

PMID24824755
PMCPMC4019476
OpenAlexW1983627497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.